Ventricular unloading is associated with increased 20s proteasome protein expression in the myocardium

Journal of Heart and Lung Transplantation

Volumn 29, Issue 1, 2010, Pages 125-132

  Wohlschlaeger, Jeremias ^a   Sixt, Stephan Urs ^a   Stoeppler, Tatjana ^a   Schmitz, Klaus Jürgen ^a   Levkau, Bodo ^a   Tsagakis, Konstantinos ^a   Vahlhaus, Christian ^b   Schmid, Christof ^b   Peters, Jürgen ^a   Schmid, Kurt Werner ^a   Milting, Hendrik ^c   Baba, Hideo Andreas ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

cardiac hypertrophy; cell cycle; circulating proteasome; ubiquitin proteasome system; ventricular unloading

Indexed keywords

20S PROTEASOME; CYCLIN D1; PROTEASOME; UBIQUITIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CELL CYCLE REGULATION; CELL NUCLEUS; CELL SIZE; CHILD; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DNA CONTENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART ASSIST DEVICE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE UNLOADING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMPLANTATION; MALE; MORPHOMETRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SARCOPLASM; SCHOOL CHILD;

ADOLESCENT; ADULT; CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; CYCLIN D1; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; MYOCYTES, CARDIAC; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN; VENTRICULAR REMODELING; YOUNG ADULT;

EID: 72249089795     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.07.022     Document Type: Article

References (23)

1. Dorn G.W., and Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 115 (2005) 527-537
2. Willis M.S., and Patterson C. Into the heart: the emerging role of the ubiquitin-proteasome system. J Mol Cell Cardiol 41 (2006) 567-579
3. von Micezs A. The nuclear ubiquitin-proteasome system. J Cell Sci 119 (2006) 1977-1984
4. Wojcik C., and DeMartino G.N. Intracellular localization of proteasomes. Int J Biochem Cell Biol 35 (2003) 579-589
5. Glickman M.H., Rubin D.M., Fried V.A., et al. The regulatory particle of the Saccharomyces cerevisiae proteasome. Mol Cell Biol 18 (1998) 3149-3162
6. Voges D., Zwickl P., and Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 68 (1999) 1015-1068
7. Pickart C.M., and Cohen R.E. Proteasomes and their kin: proteases in the machine age. Nat Rev Mol Cell Biol 5 (2004) 177-187
8. Sixt S.U., and Dahlmann B. Extracellular, circulating proteasomes and ubiquitin-incidence and relevance. Biochim Biophys Acta 1782 (2008) 817-823
9. Yew P.R. Ubiquitin-mediated proteolysis of vertebrate G1- and S-phase regulators. J Cell Physiol 187 (2001) 1-10
10. Powell S.R. The ubiquitin-proteasome system in cardiac physiology and pathology. Am J Physiol Heart Circ Physiol 291 (2006) H1-H19
11. Weekes J., Morrison K., Mullen A., et al. Hyperubiquitination of proteins in dilated cardiomyopathy. Proteomics 3 (2003) 208-216
12. Hein S., Arnon E., Kostin S., et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107 (2003) 984-991
13. Tsukamoto O., Minamino T., Okada K., et al. Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice. Biochem Biophys Res Commun 340 (2006) 1125-1133
14. Friehs I. Proteasome inhibition in hypertrophied myocardium. Am J Physiol Heart Circ Physiol 295 (2008) H1373-H1374
15. Hedhli N., Lizano P., Hong C., et al. Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload. Am J Physiol Heart Circ Physiol 295 (2008) H1385-H1393
16. Wohlschlaeger J., Schmitz K.J., Schmid C., et al. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes. Cardiovasc Res 68 (2005) 376-386
17. Gundersen H.J.G. Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. Acta Derm Venereol 57 (1977) 173-176
18. Dutaud D., Aubry L., Henry L., et al. Development and evaluation of a sandwich ELISA for quantification of the 20S proteasome in human plasma. J Immunol Methods 260 (2002) 183-193
19. Sugden P.H., and Clerk A. Cellular mechanisms of cardiac hypertrophy. J Mol Med 76 (1998) 725-746
20. Busk P.K., Bartkova J., Strom C.C., et al. Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro. Cardiovasc Res 56 (2002) 64-75
21. Busk P.K., and Hinrichsen R. Cyclin D in left ventricle hypertrophy. Cell Cycle 2 (2003) 91-95
22. Bulteau A.L., Lundberg K.C., Humphries K.M., et al. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem 276 (2001) 30057-30063
23. Powell S.R., Wang P., Katzeff H., et al. Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome. Antioxid Redox Signal 7 (2005) 538-546